Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
Background. Alpha-1 antitrypsin deficiency (AATD) is of importance in the pathogenesis of pulmonary emphysema, chronic obstructive pulmonary diseases (COPD), and bronchiectasis. Various pulmonary disorders are a typical feature of primary immunodeficiency disease (PID). This includes recurrent pulmo...
Saved in:
Main Authors: | Georg Evers, Arik Bernard Schulze, Michael Thrull, Jan-Philipp Hering, Christoph Schülke, Rainer Wiewrodt, Helmut Wittkowski, Lars Henning Schmidt, Michael Mohr |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2020/4019608 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01) -
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
by: A. Vianello, et al.
Published: (2025-01-01) -
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience
by: Georg Evers, et al.
Published: (2022-01-01) -
Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
by: Ho-Man Yeung, et al.
Published: (2022-01-01) -
The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways
by: Ahmed S. Elshikha, et al.
Published: (2025-01-01)